NEWS · STARTUPS · #2764
Reporter tests Death Clock — an AI longevity app that now sells lab-ordered biomarker panels
A reporter used Death Clock, an AI‑powered longevity app that predicts life expectancy and creates personalized prevention plans, and ordered its new lab biomarker panel feature (announced Feb 2024). Death Clock says it trained its models on about 1,200 longevity studies and actuarial tables; subscribers can order a basic blood panel for a $69 subscription (additional tests cost up to $780 and a stress test is $29) through partner labs including Quest Diagnostics, and the app updated the reporter’s projected death age after adding family history.
KEY POINTS
- A reporter used Death Clock, an AI‑powered longevity app that predicts life expectancy and creates personalized prevention plans, and ordered its new lab biomarker panel feature (announced Feb 2024).
- Death Clock says it trained its models on about 1,200 longevity studies and actuarial tables; subscribers can order a basic blood panel for a $69 subscription (additional tests cost up to $780 and a stress test is $29) through partner labs including Quest Diagnostics, and the app updated the reporter’s projected death age after adding family history.
- This matters because consumer-facing AI products are directly integrating lab biomarker ordering and predictive life‑expectancy outputs, raising questions about clinical validity, privacy, and how such forecasts influence behavior.
WHY IT MATTERS
This matters because consumer-facing AI products are directly integrating lab biomarker ordering and predictive life‑expectancy outputs, raising questions about clinical validity, privacy, and how such forecasts influence behavior.